Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Beneish M-Score: -2.86 (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADX:JULPHAR Gulf Pharmaceutical Industries PSC ADX:JULPHAR
54 GF Score
Price د.إ1.04
GF Value د.إ1.09
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gulf Pharmaceutical Industries PSC Beneish M-Score?

Gulf Pharmaceutical Industries PSC ADX:JULPHAR +0.97% 54 Beneish M-Score is -2.86 as of Jul. 24, 2026. GuruFocus rates ADX:JULPHAR with a GF Score™ of 54/100 and a GF Value™ of د.إ1.09 (Fairly Valued). The stock has 5 warning signs investors should review. Among 114 Medical Distribution companies, Gulf Pharmaceutical Industries PSC ranks better than 79.82% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.86 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Beneish M-Score or its related term are showing as below:

ADX:JULPHAR' s Beneish M-Score Range Over the Past 10 Years
Min: -6.98   Med: -2.67   Max: 0.26
Current: -2.86

During the past 13 years, the highest Beneish M-Score of Gulf Pharmaceutical Industries PSC was 0.26. The lowest was -6.98. And the median was -2.67.


Gulf Pharmaceutical Industries PSC Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Gulf Pharmaceutical Industries PSC's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gulf Pharmaceutical Industries PSC Beneish M-Score Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.17 -2.51 -2.78 -3.83 -2.72

Gulf Pharmaceutical Industries PSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.45 -0.96 -1.91 -2.72 -2.86

ADX:JULPHAR vs MCK, CAH, COR: Beneish M-Score Comparison

For the Medical Distribution subindustry, Gulf Pharmaceutical Industries PSC's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gulf Pharmaceutical Industries PSC Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Beneish M-Score falls into.


ADX:JULPHAR
54GF Score
Gulf Pharmaceutical Industries PSC ADX:JULPHAR
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gulf Pharmaceutical Industries PSC Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gulf Pharmaceutical Industries PSC for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.87+0.528 * 0.9469+0.404 * 0.4807+0.892 * 1.0486+0.115 * 1.5593
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0106+4.679 * -0.035498-0.327 * 0.8776
=-2.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was د.إ580 Mil.
Revenue was 273.4 + 279.4 + 249.7 + 348.1 = د.إ1,151 Mil.
Gross Profit was 119.7 + 84.8 + 102.2 + 143.8 = د.إ451 Mil.
Total Current Assets was د.إ1,570 Mil.
Total Assets was د.إ1,862 Mil.
Property, Plant and Equipment(Net PPE) was د.إ252 Mil.
Depreciation, Depletion and Amortization(DDA) was د.إ53 Mil.
Selling, General, & Admin. Expense(SGA) was د.إ357 Mil.
Total Current Liabilities was د.إ549 Mil.
Long-Term Debt & Capital Lease Obligation was د.إ256 Mil.
Net Income was 35 + 5.5 + 8.8 + 17 = د.إ66 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = د.إ0 Mil.
Cash Flow from Operations was 8.5 + 46.9 + 25.7 + 51.3 = د.إ132 Mil.
Total Receivables was د.إ636 Mil.
Revenue was 281.9 + 239.5 + 236.9 + 339 = د.إ1,097 Mil.
Gross Profit was 108.5 + 93.4 + 95.8 + 109.1 = د.إ407 Mil.
Total Current Assets was د.إ1,629 Mil.
Total Assets was د.إ2,031 Mil.
Property, Plant and Equipment(Net PPE) was د.إ311 Mil.
Depreciation, Depletion and Amortization(DDA) was د.إ115 Mil.
Selling, General, & Admin. Expense(SGA) was د.إ337 Mil.
Total Current Liabilities was د.إ529 Mil.
Long-Term Debt & Capital Lease Obligation was د.إ471 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(579.8 / 1150.6) / (635.6 / 1097.3)
=0.503911 / 0.57924
=0.87

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(406.8 / 1097.3) / (450.5 / 1150.6)
=0.370728 / 0.391535
=0.9469

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1569.8 + 252.2) / 1862.1) / (1 - (1629.1 + 311.3) / 2031.4)
=0.021535 / 0.044797
=0.4807

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1150.6 / 1097.3
=1.0486

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(115.1 / (115.1 + 311.3)) / (52.8 / (52.8 + 252.2))
=0.269934 / 0.173115
=1.5593

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(356.6 / 1150.6) / (336.5 / 1097.3)
=0.309925 / 0.306662
=1.0106

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((255.6 + 549.2) / 1862.1) / ((471.3 + 529.1) / 2031.4)
=0.4322 / 0.492468
=0.8776

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(66.3 - 0 - 132.4) / 1862.1
=-0.035498

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gulf Pharmaceutical Industries PSC has a M-score of -2.86 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.86 mean?
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a Beneish M-Score of -2.86 as of Jul. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. According to the industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #23 out of 114 companies in the Medical Distribution industry, placing it in the top 20.2%.
Is Gulf Pharmaceutical Industries PSC's Beneish M-Score too high?
Gulf Pharmaceutical Industries PSC's current Beneish M-Score is -2.86. Based on the distribution chart, Gulf Pharmaceutical Industries PSC ranks #23 out of 114 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's Beneish M-Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #23 out of 114 companies for Beneish M-Score. This places Gulf Pharmaceutical Industries PSC in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. Gulf Pharmaceutical Industries PSC's current Beneish M-Score is -2.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.09, compared to a current price of د.إ1.04 — trading 4.6% below its estimated fair value. The current Beneish M-Score is -2.86. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current Beneish M-Score is -2.86 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued. The current stock price of د.إ1.04 is trading 4.6% below its estimated GF Value™ of د.إ1.09. GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.

Key valuation signals for ADX:JULPHAR:

  • Beneish M-Score: -2.86
  • GF Value™: د.إ1.09 vs. price of د.إ1.04 (4.6% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gulf Pharmaceutical Industries PSC Business Description

Address Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
54GF Score

Get the complete analysis for ADX:JULPHAR

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ1.04
Price
د.إ1.09
GF Value